EA200200584A1 - Средство для лечения гепатита c - Google Patents

Средство для лечения гепатита c

Info

Publication number
EA200200584A1
EA200200584A1 EA200200584A EA200200584A EA200200584A1 EA 200200584 A1 EA200200584 A1 EA 200200584A1 EA 200200584 A EA200200584 A EA 200200584A EA 200200584 A EA200200584 A EA 200200584A EA 200200584 A1 EA200200584 A1 EA 200200584A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hepatitis
treatment
triaziridide
thiophosphoric
alkaloids
Prior art date
Application number
EA200200584A
Other languages
English (en)
Russian (ru)
Inventor
Вассиль Новицки
Original Assignee
Вассиль Новицки
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вассиль Новицки filed Critical Вассиль Новицки
Publication of EA200200584A1 publication Critical patent/EA200200584A1/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EA200200584A 2000-03-22 2001-03-20 Средство для лечения гепатита c EA200200584A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (fr) 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c

Publications (1)

Publication Number Publication Date
EA200200584A1 true EA200200584A1 (ru) 2003-06-26

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200200584A EA200200584A1 (ru) 2000-03-22 2001-03-20 Средство для лечения гепатита c

Country Status (17)

Country Link
JP (1) JP2003527414A (fr)
KR (1) KR20020087045A (fr)
CN (1) CN1416347A (fr)
AT (1) AT408719B (fr)
AU (1) AU2001239000A1 (fr)
BG (1) BG107088A (fr)
BR (1) BR0107211A (fr)
CA (1) CA2389173A1 (fr)
EA (1) EA200200584A1 (fr)
HR (1) HRP20020367A2 (fr)
IL (1) IL149314A0 (fr)
IS (1) IS6360A (fr)
MA (1) MA25509A1 (fr)
MX (1) MXPA02004993A (fr)
NO (1) NO20022253L (fr)
PL (1) PL365000A1 (fr)
WO (1) WO2001070203A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (fr) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
EP2083825A4 (fr) * 2006-09-26 2009-11-04 Addiction Res Inst Inc Compositions de traitement de l'hépatite c et procédés d'utilisation des compositions de traitement de l'hépatite c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
NO20022253D0 (no) 2002-05-10
KR20020087045A (ko) 2002-11-21
AT408719B (de) 2002-02-25
WO2001070203A2 (fr) 2001-09-27
BG107088A (en) 2003-05-30
CA2389173A1 (fr) 2001-09-27
PL365000A1 (en) 2004-12-27
CN1416347A (zh) 2003-05-07
HRP20020367A2 (en) 2004-02-29
JP2003527414A (ja) 2003-09-16
WO2001070203A3 (fr) 2002-09-06
BR0107211A (pt) 2004-01-06
NO20022253L (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
IS6360A (is) 2002-04-24
IL149314A0 (en) 2002-11-10
AU2001239000A1 (en) 2001-10-03
ATA4812000A (de) 2001-07-15
MA25509A1 (fr) 2002-07-01

Similar Documents

Publication Publication Date Title
DK1161452T3 (da) Kovalent forbundne insulindimerer
LT2003017A (en) Polymorphs of an epothilone analog
EA200101046A1 (ru) Производные индигоидных бис-индолов
ES2064329T3 (es) Compuestos hexaciclicos.
NO905428L (no) Fremgangsmaate for fremstilling av hiv-proteaseinhibitorerfor behandling av aids.
SE9702001D0 (sv) Novel compounds
EE200200183A (et) Meetod polüisobuteenfenooli sisaldavate Mannichi aduktide saamiseks
NO882218L (no) Fremgangsmaate for fremstilling av fosforholdige hmg-coa reduktase-inhibitorer.
NO882219D0 (no) Fremgangsmaate for fremstilling av fosforholdige hmg-coa reduktase-inhibitorer.
EA200200584A1 (ru) Средство для лечения гепатита c
GB9907571D0 (en) Compounds
ID21520A (id) Proses untuk produksi fermentatif cephalosporin terdeasilasi
GR900100112A (el) Μεθοδος παρασκευης ενωσεων πυριμιδο-πυριμιδινης αναστολεων της λιποξυγενασης.
EA200101106A1 (ru) Фармацевтический комплекс
ES2097778T3 (es) Procedimiento para la preparacion de compuestos de 2-halo-3-sustituido-5-arilpirroles insecticidas, nematocidas y acaricidas.
EE9900373A (et) Protsess bensotiasoloonühendite valmistamiseks
NO20014051D0 (no) Fremgangsmate for fremstilling av et noringsmiddel
ATE298336T1 (de) Verfahren zur herstellung von thiazolidinedion- derivaten und zwischenprodukte
NO20020328L (no) Fremgangsmåte for fremstilling av 4-cyano-2-aminometyltiazol
SE9901340D0 (sv) Novel process
ES2085939T3 (es) Procedimiento para la preparacion de compuestos insecticidas, nematocidas y acaricidas de 4-sustituido-5-(trifluorometil)pirrol-3-carbonitrilo.
SE9900693D0 (sv) Novel process
DE50203367D1 (de) Verfahren zur herstellung von orthocarbonsäuretrialkylestern
NO902749L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme bis-(benzylpyrrolidin)-derivater.
SE9901338D0 (sv) Novel process